High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Clinical Chemistry

Background:

• The clinical impact of accumulating toxic metabolites like oxalate in kidney failure patients remains unclear.
• Understanding the role of oxalate in cardiovascular complications is crucial for managing patients with chronic kidney disease.

Purpose of the Study:

• To investigate the association between serum oxalate concentrations and the risk of all-cause mortality and cardiovascular events in patients with kidney failure undergoing chronic dialysis.
• To validate these findings in an independent cohort of dialysis patients.

Main Methods:

• A post-hoc analysis of the German Diabetes Dialysis (4D) Study cohort (1255 European patients) and validation in a US cohort (104 patients) were conducted.
• Serum oxalate concentrations were measured at baseline, and patients were followed for cardiovascular events and mortality.
• Statistical analyses included Cox proportional hazards models, competing risk regression, and restricted cubic spline modeling.

Main Results:

• A median serum oxalate concentration of 42.4 µM was observed in 1108 patients.
• Patients in the highest oxalate quartile (≥59.7 µM) exhibited a 40% increased risk of cardiovascular events and a 62% increased risk of sudden cardiac death compared to the lowest quartile (≤29.6 µM).
• These associations persisted after accounting for competing risks and treating oxalate as a continuous variable.

Conclusions:

• Elevated serum oxalate is identified as a novel risk factor for cardiovascular events and sudden cardiac death in patients on dialysis.
• Further research is recommended to explore oxalate-lowering strategies to mitigate cardiovascular mortality in this patient population.